论文部分内容阅读
头颈鳞癌(HNSCC)患者心血管疾病(CVD)发生的风险尚没有得到足够重视。该文作者对2011-2013年间接受辅助放(化)疗的患者进行回顾分析。根据Framingham风险评分(FRS),对CVD的发生进行10年评估。结果:115例临床Ⅲ/Ⅳ期HNSCC患者纳入研究,平均随访2a,23%的患者出现CVD。喉
The risk of cardiovascular disease (CVD) in patients with head and neck squamous cell carcinoma (HNSCC) is yet to receive enough attention. The authors retrospectively analyzed patients who underwent adjuvanted radiotherapy between 2011 and 2013. A 10-year assessment of the incidence of CVD was based on the Framingham Risk Score (FRS). Results: One hundred and fifteen patients with stage III / IV HNSCC were enrolled in the study. The mean follow-up was 2a, with 23% of patients having CVD. throat